ERCO Pharma is specialized in in silico modeling of the main barrier in human skin. Their model of the intercellular lipid barrier makes it possible to predict permeability through skin and also the effects of formulation components, such as excipients and penetration enhancers. This technology makes it possible to improve existing products and to provide assistance during the development of new dermal or transdermal drug formulations.